Home Reimbursed medicines Deferasirox
Deferasirox — maximum prices and reimbursement
The CANAMED catalogue contains 56 medicines with the active substance Deferasirox, from 7 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Deferasirox there are 56 authorised medicines in the CANAMED catalogue, with maximum retail prices between 102.51 and 2171.72 RON, from 7 manufacturers. For 17 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Deferasirox
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| REDITENS 90 mg | PHAROS MT LTD. - MALTA | 102.51 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~102.51 RON; you ~0.00 RON* |
PR |
| DEFERASIROX STADA 180 mg | STADA ARZNEIMITTEL AG - GERMANIA | 151.04 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~151.04 RON; you ~0.00 RON* |
PR |
| REDITENS 180 mg | PHAROS MT LTD. - MALTA | 160.85 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~160.85 RON; you ~0.00 RON* |
PR |
| DEFERASIROX STADA 360 mg | STADA ARZNEIMITTEL AG - GERMANIA | 381.45 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~381.45 RON; you ~0.00 RON* |
PR |
| DEFERASIROX ACCORD 180 mg | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | 687.91 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~506.66 RON* |
PR |
| EXJADE 180 mg | NOVARTIS PHARMA GMBH - GERMANIA | 766.50 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~585.25 RON* |
PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | 1090.98 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~909.73 RON* |
PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | 1090.98 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~909.73 RON* |
PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | 1090.98 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~909.73 RON* |
PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | 1090.98 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~181.25 RON; you ~909.73 RON* |
PR |
| EXJADE 360 mg | NOVARTIS PHARMA GMBH - GERMANIA | 1360.87 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~903.13 RON* |
PR |
| DEFERASIROX ACCORD 360 mg | ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA | 1392.70 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~934.96 RON* |
PR |
| REDITENS 360 mg | PHAROS MT LTD. - MALTA | 2171.72 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~1713.98 RON* |
PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | 2171.72 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~1713.98 RON* |
PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | 2171.72 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~1713.98 RON* |
PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | 2171.72 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~1713.98 RON* |
PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | 2171.72 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~457.74 RON; you ~1713.98 RON* |
PR |
| DEFERASIROX MSN LABORATORIES 180 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX MSN LABORATORIES 180 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX MSN LABORATORIES 360 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX MSN LABORATORIES 360 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX MSN LABORATORIES 90 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX MSN LABORATORIES 90 mg | PHARMADOX HEALTHCARE LTD. - MALTA | — | not reimbursed | PR |
| DEFERASIROX SANEXCEL 360 mg | PHARMATEN S.A. - GRECIA | — | not reimbursed | PR |
| DEFERASIROX SANEXCEL 360 mg | PHARMATEN S.A. - GRECIA | — | not reimbursed | PR |
| DEFERASIROX STADA 180 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 180 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 180 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 180 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 360 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 360 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 360 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 360 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 90 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 90 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 90 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 90 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| DEFERASIROX STADA 90 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| EXJADE 180 mg | NOVARTIS PHARMA GMBH - GERMANIA | — | not reimbursed | PR |
| EXJADE 180 mg | NOVARTIS PHARMA GMBH - GERMANIA | — | not reimbursed | PR |
| EXJADE 360 mg | NOVARTIS PHARMA GMBH - GERMANIA | — | not reimbursed | PR |
| EXJADE 360 mg | NOVARTIS PHARMA GMBH - GERMANIA | — | not reimbursed | PR |
| REDITENS 180 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| REDITENS 180 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| REDITENS 360 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| REDITENS 360 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| REDITENS 90 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| REDITENS 90 mg | PHAROS MT LTD. - MALTA | — | not reimbursed | PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 180 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
| ZEOKS 360 mg | SYNTHON HISPANIA, S.L. - SPANIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Deferasirox in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
- DEFERASIROX ACCORD 180 mg
- DEFERASIROX ACCORD 360 mg
- DEFERASIROX MSN LABORATORIES 180 mg
- DEFERASIROX MSN LABORATORIES 180 mg
- DEFERASIROX MSN LABORATORIES 360 mg
- DEFERASIROX MSN LABORATORIES 360 mg
- DEFERASIROX MSN LABORATORIES 90 mg
- DEFERASIROX MSN LABORATORIES 90 mg
- DEFERASIROX SANEXCEL 360 mg
- DEFERASIROX SANEXCEL 360 mg
- DEFERASIROX STADA 180 mg
- DEFERASIROX STADA 180 mg
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Dabigatran etexilat
- Dapagliflozin
- Diclofenac
- Duloxetin
- Desloratadin
- Donepezil
- Dexamethason
- Dimethyl fumarate
- Dasatinib
- Diverse
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Deferasirox
-
Is Deferasirox reimbursed?
Yes. For 17 of the catalogue entries with Deferasirox we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Deferasirox?
The maximum retail prices (the CANAMED legal cap) for medicines with Deferasirox are between 102.51 and 2171.72 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Deferasirox is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Deferasirox are in the CANAMED catalogue?
The CANAMED catalogue holds 56 authorised medicines with the active substance Deferasirox — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go